NZ Herald
  • Home
  • Latest news
  • Herald NOW
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
  • Herald NOW
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Politics
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Herald NOW
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / New Zealand

Helen Petousis-Harris: Why we shouldn't worry about vaccine trial's 'pause'

By Helen Petousis-Harris
NZ Herald·
10 Sep, 2020 02:22 AM4 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Yesterday, AstraZeneca pushed the pause button on its late-stage trials of a Covid-19 vaccine. Photo / AP

Yesterday, AstraZeneca pushed the pause button on its late-stage trials of a Covid-19 vaccine. Photo / AP

Opinion

COMMENT:

Yesterday, AstraZeneca pushed the pause button on its late-stage trials of a Covid-19 vaccine.

A clinical trial participant has experienced a serious health event and an investigation is underway to determine the cause. What does it mean?

With more than 200 Covid-19 vaccines now under development we are going to start seeing participants in the clinical trials have heath events.

These events may or may not be completely unrelated to the vaccine under study.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

When you have what will ultimately be hundreds of thousands of people under observation in clinical trials, some will get sick, especially when you start recruiting older people into these studies.

When this happens sometimes the trial will need to be halted while the event is investigated, and a lot of questions answered.

Did the person receive the vaccine or a placebo? How long after the injection did this event occur? What sort of health event is this?

Advertisement
Advertise with NZME.

For example, is it heart attack? An infection? An injury? A seizure? Something else? Is this event biologically plausibly explained by receipt of the vaccine?

As the Covid-19 vaccine trials progress we are going to see periodic haltings of these trials.

This is actually the second time the Oxford/AstraZeneca vaccine trials have paused.

One reason for halting a trial is because a participant has had an adverse medical event.

We must accept the possibility that one, or some, of these new vaccines may have safety problems and fail to progress further.

We must also accept that if the event has been determined not caused by the vaccine the trial may resume. This is normal practice.

Who oversees the safety data on the trials?

Each clinical trial has a Data and Safety Monitoring Board (DSMB).

This is an independent group of people who have expertise in the disease, the drug, statistics, or other relevant fields.

While they will periodically review the study data for evidence of study-related adverse events, they can also make recommendations to the developer about continuing the study, modifying the study, or even terminating the study.

Advertisement
Advertise with NZME.

When a serious event occurs they are alerted and will convene urgently.

The data they review, and discussions are confidential.

In the case of Covid-19 vaccines, a large pool of safety-trained people have been recruited into a meta-DSMB.

This team can liaise across all the individual DSMBs across all of the different vaccine products.

This can help ensure the same level of rigour and standards are applied to all Covid-19 vaccines – at least those receiving support from CEPI, or the Coalition for Epidemic Preparedness Innovation.

About the vaccine

This vaccine was developed at Oxford University. Pharma giant AstraZeneca have partnered with Oxford to make it.

Advertisement
Advertise with NZME.

The vaccine is called a non-replicating viral vector vaccine and it uses an adenovirus that has had the gene for the SARS-CoV-2 spike protein inserted in to it.

When injected, the vaccinee's own cells will make the spike protein and the immune system generates a response.

There is some experience with viral vector vaccines in humans and so far there are no particular safety concerns identified associated with this particular viral vector construct (ChAdOx1).

According to the New York Times, the adverse event is a case of transverse myelitis - but this has not yet been confirmed by the company.

Transverse myelitis is an inflammatory condition that affects the spinal cord.

Biologically speaking many infections, such as the herpes and influenza viruses are known to cause this condition.

Advertisement
Advertise with NZME.

It has even been reported associated with Covid-19. Historically there have been rare cases of such immune mediated inflammatory disorders associated with vaccines, but a firm causal link has never been established.

This event does not affect other trials, particularly those using different vaccine platforms.
It also demonstrates that safety is being taken very seriously.

We need to be patient and let the trials run their course.

• Associate Professor Helen Petousis-Harris is a University of Auckland vaccinologist. The full version of this editorial, republished with permission, can be viewed on SciBlogs.co.nz.

Save

    Share this article

Latest from New Zealand

Premium
Auckland

Death on a Remuera street: The tall, ‘harmless’ man with a tragic background

05 Jul 09:16 PM
New Zealand

Noel Edmonds to marry again: British TV star proposes in hot tub in NZ

05 Jul 09:00 PM
New ZealandUpdated

French fare leaves sour taste after bakers vanish leaving unpaid bills

05 Jul 08:41 PM

There’s more to Hawai‘i than beaches and buffets – here’s how to see it differently

sponsored
Advertisement
Advertise with NZME.

Latest from New Zealand

Premium
Death on a Remuera street: The tall, ‘harmless’ man with a tragic background

Death on a Remuera street: The tall, ‘harmless’ man with a tragic background

05 Jul 09:16 PM

Jules Turk, 74, was a common sight on Shore Rd in Remuera, with his spiky, coloured hair.

Noel Edmonds to marry again: British TV star proposes in hot tub in NZ

Noel Edmonds to marry again: British TV star proposes in hot tub in NZ

05 Jul 09:00 PM
French fare leaves sour taste after bakers vanish leaving unpaid bills

French fare leaves sour taste after bakers vanish leaving unpaid bills

05 Jul 08:41 PM
Premium
Businessman loses $11.5k in bank transfer error, wages 5yr legal battle to ID recipient

Businessman loses $11.5k in bank transfer error, wages 5yr legal battle to ID recipient

05 Jul 08:00 PM
From early mornings to easy living
sponsored

From early mornings to easy living

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP